Cost-Effectiveness of Percutaneous Coronary Interventions

[1]  S. Murphy,et al.  Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. , 2004, Journal of the American College of Cardiology.

[2]  M. Sculpher,et al.  Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial. , 2002, European heart journal.

[3]  M. Leon,et al.  Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.

[4]  A. Yeung,et al.  Use of localised intracoronary β radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial , 2002, The Lancet.

[5]  P. Lavori,et al.  Cost-Effectiveness of a Conservative, Ischemia-Guided Management Strategy After Non–Q-Wave Myocardial Infarction: Results of a Randomized Trial , 2002, Circulation.

[6]  Samin K. Sharma,et al.  A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). , 2002, The American journal of cardiology.

[7]  G. Stone,et al.  Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction: Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial , 2001, Circulation.

[8]  G. Stone,et al.  Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial. , 2001, Journal of the American College of Cardiology.

[9]  B. Hout,et al.  Cost-efficacy in interventional cardiology, results from the EPISTENT study , 2001 .

[10]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[11]  J. Ottervanger,et al.  Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction , 2001, Heart.

[12]  G. Mintz,et al.  Prolonged Antiplatelet Therapy to Prevent Late Thrombosis After Intracoronary &ggr;-Radiation in Patients With In-Stent Restenosis: Washington Radiation for In-Stent Restenosis Trial Plus 6 Months of Clopidogrel (WRIST PLUS) , 2001, Circulation.

[13]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[14]  D. Carrié,et al.  Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. BET (Benefit Evaluation of Direct Coronary Stenting) Study Group. , 2001, The American journal of cardiology.

[15]  D. Baim,et al.  Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter. , 2001, American heart journal.

[16]  D. Mark,et al.  Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). , 2001, The American journal of medicine.

[17]  Adrian F. Hernandez,et al.  Highlights from the American Heart Association annual scientific sessions 2002: November 17 to 20, 2002. , 2001, American heart journal.

[18]  P. Teirstein,et al.  Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. , 2001, The New England journal of medicine.

[19]  R. Califf,et al.  Economic Assessment of Platelet Glycoprotein IIb/IIIa Receptor Blockade With Abciximab and Low-Dose Heparin During Percutaneous Coronary Revascularization: Results From the EPILOG Randomized Trial , 2000, Circulation.

[20]  J. Moses,et al.  Randomized Comparison of Elective Stent Implantation and Coronary Balloon Angioplasty Guided by Online Quantitative Angiography and Intracoronary Doppler , 2000, Circulation.

[21]  P. Serruys,et al.  Randomized Comparison of Primary Stenting and Provisional Balloon Angioplasty Guided by Flow Velocity Measurement , 2000, Circulation.

[22]  P. Teirstein.  Fulfilling the promise of percutaneous angioplasty. , 2000, Circulation.

[23]  R. Stables,et al.  Trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty and primary stent implantation in patients with multivessel coronary artery disease. , 2000, Current opinion in cardiology.

[24]  W. Weintraub,et al.  Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST). , 2000, The American journal of cardiology.

[25]  B. Gersh,et al.  Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. , 2000, Circulation.

[26]  D. Cutlip.  Stent Thrombosis: Historical Perspectives and Current Trends , 2000, Journal of Thrombosis and Thrombolysis.

[27]  L. Wallentin,et al.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial , 2000, The Lancet.

[28]  J. J. Griffin,et al.  Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial , 2000, The Lancet.

[29]  P. Fitzgerald,et al.  Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. , 2000, Circulation.

[30]  M. Leon,et al.  Intracoronary β-Radiation Therapy Inhibits Recurrence of In-Stent Restenosis , 2000 .

[31]  Bruce R. Brodie,et al.  Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .

[32]  J. Spinelli,et al.  Improved clinical outcome after widespread use of coronary-artery stenting in Canada. , 1999, The New England journal of medicine.

[33]  C. Di Mario,et al.  Direct coronary stenting without predilation. , 1999, Journal of the American College of Cardiology.

[34]  R. Stables,et al.  Design of the 'Stent or Surgery' trial (SoS): a randomized controlled trial to compare coronary artery bypass grafting with percutaneous transluminal coronary angioplasty and primary stent implantation in patients with multi-vessel coronary artery disease. , 1999, Seminars in interventional cardiology : SIIC.

[35]  S. Pirelli,et al.  Stent implantation without predilation in patients with a single, noncalcified coronary artery lesion. , 1999, The American journal of cardiology.

[36]  S. Saito,et al.  Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: Final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[37]  W. Weintraub,et al.  Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. , 1999, Journal of the American College of Cardiology.

[38]  J L Ritchie,et al.  Coronary artery stent outcomes in a Medicare population: less emergency bypass surgery and lower mortality rates in patients with stents. , 1999, American heart journal.

[39]  P. Serruys,et al.  Late coronary occlusion after intracoronary brachytherapy. , 1999, Circulation.

[40]  Sankey V. Williams,et al.  ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). , 1999, Journal of the American College of Cardiology.

[41]  E. DeLong,et al.  Acute and long-term cost implications of coronary stenting. , 1999, Journal of the American College of Cardiology.

[42]  R. Califf,et al.  Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. , 1999, Circulation.

[43]  E. Topol.  Coronary-artery stents--gauging, gorging, and gouging. , 1998, The New England journal of medicine.

[44]  David P Miller,et al.  Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block , 1998, Journal of the American College of Cardiology.

[45]  L. Harrell,et al.  Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long-term follow-up results. , 1998, Journal of the American College of Cardiology.

[46]  S. Pocock,et al.  Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting , 1998, The Lancet.

[47]  B. Griffith,et al.  Feasibility of combined percutaneous transluminal angioplasty and minimally invasive direct coronary artery bypass in patients with multivessel coronary artery disease. , 1998, Circulation.

[48]  Antonio Colombo,et al.  Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) , 1998, The Lancet.

[49]  T. Investigators.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.

[50]  R. Kleiger,et al.  Correction: Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy. , 1998, The New England journal of medicine.

[51]  I. Palacios,et al.  In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Gianturco-Roubin in Acute Myocardial Infarction. , 1998, The American journal of cardiology.

[52]  E. Topol,et al.  A call for provisional stenting: the balloon is back! , 1998, Circulation.

[53]  Stone Gw.  Stenting and IIb/IIIa Receptor Blockade in Acute Myocardial Infarction: An Introduction to the CADILLAC Trial. , 1998 .

[54]  P. Fitzgerald,et al.  'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). , 1998, Circulation.

[55]  Samin K. Sharma,et al.  Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) , 1998, Circulation.

[56]  R. Gibbons,et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review , 1997 .

[57]  E Fleck,et al.  Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). , 1997, Circulation.

[58]  RITA-2 trial participants.  Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial , 1997, The Lancet.

[59]  Epilog Investigators,et al.  Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[60]  R A Schatz,et al.  Catheter-based radiotherapy to inhibit restenosis after coronary stenting. , 1997, The New England journal of medicine.

[61]  N. Geller,et al.  Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. , 1997, Circulation.

[62]  J. O’Keefe,et al.  Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. , 1997, Journal of the American College of Cardiology.

[63]  L Chiariello,et al.  A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. , 1997, The New England journal of medicine.

[64]  D. Baim,et al.  The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs. , 1997, The American journal of cardiology.

[65]  D. Mark,et al.  Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. , 1997, The New England journal of medicine.

[66]  J. Madias.  Bypass angioplasty revascularization investigation. , 1997, The New England journal of medicine.

[67]  J S Martin,et al.  A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial Infarction , 1996 .

[68]  W. Parmley,et al.  Initial cost of primary angioplasty for acute myocardial infarction. , 1996, Journal of the American College of Cardiology.

[69]  James T. Willerson,et al.  Appointment of New Associate Editor for Circulation , 1996 .

[70]  E J Topol,et al.  Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. , 1996, Circulation.

[71]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[72]  Russell L. Stogsdill,et al.  A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. , 1996, JAMA.

[73]  M. Nobuyoshi,et al.  Initial and six months outcome of Palmaz-Schatz stent implantation: Stress/Benestent equivalent vs non-equivalent lesions , 1996 .

[74]  A S Kosinski,et al.  A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). , 1995, Circulation.

[75]  S. Pocock,et al.  Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery , 1995, The Lancet.

[76]  H. Krumholz,et al.  In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. , 1995, Circulation.

[77]  David P Miller,et al.  In-hospital cost of percutaneous coronary revascularization. Critical determinants and implications. , 1995, Circulation.

[78]  R. Petersen,et al.  Cost-effectiveness and predictors of early extubation. , 1995, The Annals of thoracic surgery.

[79]  W. O’Neill,et al.  Procedural cost of new interventional devices. , 1994, The American journal of cardiology.

[80]  W. O’Neill,et al.  Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. , 1994, Journal of the American College of Cardiology.

[81]  S. Yusuf,et al.  Effect of coronary artery bypass graft surgery on survival , 1994, The Lancet.

[82]  M. D. Joy,et al.  Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1994, The Lancet.

[83]  J. Mcmanus.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994 , 1994 .

[84]  T. Chalmers,et al.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.

[85]  E J Topol,et al.  Caveats about elective coronary stenting. , 1994, The New England journal of medicine.

[86]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[87]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[88]  C. Simpfendorfer,et al.  Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease. , 1994, The American journal of cardiology.

[89]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[90]  L. Goldman,et al.  Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. , 1994, Circulation.

[91]  L. Wilkins.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[92]  D. Ricci,et al.  A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. , 1993, The New England journal of medicine.

[93]  R. Califf,et al.  A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease , 1993 .

[94]  N. Schork,et al.  Analysis of Coronary Angioplasty Practice in the United States With an Insurance‐Claims Data Base , 1993, Circulation.

[95]  K. Bailey,et al.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.

[96]  RITA-2 trial participants.  Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1993, The Lancet.

[97]  S. Schnitt,et al.  Long-term results of directional coronary atherectomy: predictors of restenosis. , 1992, Journal of the American College of Cardiology.

[98]  J. Simpson,et al.  Restenosis after directional coronary atherectomy. , 1992, Journal of the American College of Cardiology.

[99]  P. Hartigan,et al.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. , 1992, The New England journal of medicine.

[100]  P. Kudenchuk,et al.  Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. , 1991, Journal of the American College of Cardiology.

[101]  J. O’Keefe,et al.  Safety and cost effectiveness of combined coronary angiography and angioplasty. , 1991, American heart journal.

[102]  P. Serruys,et al.  Stenting of coronary arteries: has a modern Pandora's box been opened? , 1991, Journal of the American College of Cardiology.

[103]  F. Sonnenberg,et al.  Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. , 1990, Annals of internal medicine.

[104]  R. Califf,et al.  Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. , 1990, Circulation.

[105]  E. Varnauskas.  Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. , 1988, The New England journal of medicine.

[106]  D. Faxon,et al.  Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. , 1988, The New England journal of medicine.

[107]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.

[108]  W. C. Sheldon,et al.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.

[109]  E. Passamani,et al.  A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. , 1985, The New England journal of medicine.

[110]  F. Harrell,et al.  Natural history of patients with single-vessel disease suitable for percutaneous transluminal coronary angioplasty. , 1983, The American journal of cardiology.

[111]  M. Weinstein,et al.  Cost–effectiveness of Coronary Artery Bypass Surgery , 1982, Circulation.

[112]  W. Siegenthaler,et al.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.

[113]  M. Weinstein,et al.  Allocation of Resources to Manage Hypertension , 1977 .

[114]  G. Levine,et al.  In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. , 2002, The American journal of cardiology.

[115]  L. Levin,et al.  Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease. , 2002, European heart journal.

[116]  Wong Ck,et al.  Recognising “painless” heart attacks , 2002 .

[117]  P. Serruys,et al.  Arterial revascularization therapy study: a randomized trial of stenting in multivessel coronary disease versus bypass surgery. 3 year results , 2002 .

[118]  L. Wallentin,et al.  ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease. The FRISC II ECG substudy , 2002 .

[119]  H. Schieffer,et al.  Long-term follow-up of a randomized study of primary stenting versus angioplasty in acute myocardial infarction. , 2001, The American journal of medicine.

[120]  Marshall A. Lichtman,et al.  Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961 , 2000 .

[121]  K. Jolly,et al.  Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. , 2000, Health technology assessment.

[122]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[123]  G. Taylor,et al.  Comparative cost of myocardial revascularization: percutaneous transluminal angioplasty and coronary artery bypass surgery. , 1985, Journal of the American College of Cardiology.